CCP
ELV icon

Clough Capital Partners’s Elevance Health ELV Stock Holding History

Clough Capital Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-19,110
Closed -$8.31M – 126
2025
Q1 		$8.31M Buy
+19,110
New +$7.67M 1.04% 39
2024
Q4 		– Sell
-32,284
Closed -$16.8M – 134
2024
Q3 		$16.8M Buy
32,284
+6,375
+25% +$3.41M 1.72% 18
2024
Q2 		$14M Buy
25,909
+2,595
+11% +$1.37M 1.53% 19
2024
Q1 		$12.1M Buy
23,314
+19,115
+455% +$9.51M 1.33% 31
2023
Q4 		$1.98M Sell
4,199
-801
-16% -$370K 0.22% 77
2023
Q3 		$2.18M Hold
5,000
– – 0.23% 89
2023
Q2 		$2.22M Hold
5,000
– – 0.22% 110
2023
Q1 		$2.3M Hold
5,000
– – 0.25% 102
2022
Q4 		$2.56M Buy
+5,000
New +$2.54M 0.26% 83
2021
Q3 		– Sell
-33,725
Closed -$12.9M – 125
2021
Q2 		$12.9M Sell
33,725
-41,250
-55% -$15.8M 0.7% 57
2021
Q1 		$26.9M Buy
+74,975
New +$24.1M 1.2% 23
2019
Q2 		– Sell
-66,458
Closed -$19.1M – 117
2019
Q1 		$19.1M Buy
66,458
+30,735
+86% +$8.89M 1.67% 19
2018
Q4 		$9.38M Buy
+35,723
New +$9.82M 1.1% 28
2015
Q2 		– Sell
-44,780
Closed -$6.91M – 210
2015
Q1 		$6.91M Sell
44,780
-48,700
-52% -$6.93M 0.23% 120
2014
Q4 		$11.7M Buy
93,480
+45,550
+95% +$5.63M 0.42% 89
2014
Q3 		$5.73M Sell
47,930
-148,200
-76% -$17M 0.21% 112
2014
Q2 		$21.1M Sell
196,130
-113,670
-37% -$11.7M 0.67% 60
2014
Q1 		$30.8M Buy
309,800
+52,500
+20% +$4.75M 0.96% 34
2013
Q4 		$23.8M Sell
257,300
-34,400
-12% -$3.06M 0.78% 46
2013
Q3 		$24.4M Buy
291,700
+88,800
+44% +$7.61M 0.76% 45
2013
Q2 		$16.6M Buy
+202,900
New +$15.2M 0.55% 64

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Clough Capital Partners's ELV Position: Q2 2025 in Review

Clough Capital Partners sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 19,110 shares — an estimated $8.31M sold.

Clough Capital Partners first reported a position in ELV in Q2 2013 and held it in 21 quarters. The position peaked at $30.8M in Q1 2014. 1,590 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • Clough Capital Partners reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • Clough Capital Partners sold 19,110 Elevance Health shares in Q2 2025, an estimated $8.31M.
  • Clough Capital Partners first reported a position in Elevance Health in Q2 2013 and held it in 21 quarters.
  • Clough Capital Partners's Elevance Health position peaked at $30.8M in Q1 2014.
  • 1,590 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Clough Capital Partners's 13F filing for Q2 2025, filed 14 Aug 2025.